Tag: America
Browse our exclusive articles!
Signum out-licenses SIG990 to Dermata to develop new topical treatment for rosacea
US-based biotechnology firm Signum Dermalogix has out-licensed SIG990, a new anti-inflammatory compound, to Dermata Therapeutics for the development of a topical product to treat...
Cipher Pharma buys Canadian rights to novel treatment for psoriasis and RA from Can-Fite Biopharma
Cipher Pharmaceuticals Inc., a rapidly growing specialty pharmaceutical dermatology company, has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed...
Omega-3 fatty acids and vitamin D may control brain serotonin
Although essential marine omega-3 fatty acids and vitamin D have been shown to improve cognitive function and behavior in the context of certain brain...
Graphene shows potential as novel anti-cancer therapeutic strategy
University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells. This new development opens up...
Salix inks deal with Indian pharma company to sell its drugs in Canada
Salix Pharamaceuticals and Indian pharmaceutical company Lupin announced Friday that they have entered into a distribution agreement that grants Lupin the exclusive right to...
